Skip to main content

Table 2 Inclusion criteria

From: Rivaroxaban in patients with abdominal aortic aneurysm and high-sensitivity C-reactive protein elevation (BANBOO): study protocol for a randomized, controlled trial

Inclusion criteria

1. 18–85 years old

2. AAA diagnosed by CTA; the maximal diameter of aneurysm is 30–50 mm

3. Serum hs-CRP ≥ 2 mg/L

4. Written informed consent

  1. AAA abdominal aortic aneurysm, CTA computed tomography angioplasty, hs-CRP high-sensitivity C-reactive protein
Back to article page

Trials

ISSN: 1745-6215